Mesirow Financial Investment Management - Fixed Income’s Pfizer PFE Stock Holding History

Mesirow Financial Investment Management - Fixed Income’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-19,101	Closed	-$588K	–	221
2016 Q4	$588K	Hold	19,101	–	–	0.04%	152
2016 Q3	$613K	Sell	19,101 -22,139	-54%	-$740K	0.04%	147
2016 Q2	$1.38M	Sell	41,240 -25,599	-38%	-$817K	0.08%	109
2016 Q1	$1.88M	Hold	66,839	–	–	0.86%	38
2015 Q4	$2.05M	Sell	66,839 -121	-0.2%	-$3.81K	0.94%	28
2015 Q3	$2M	Sell	66,960 -5,923	-8%	-$190K	0.56%	76
2015 Q2	$2.32M	Sell	72,883 -1,140	-2%	-$37.2K	0.55%	70
2015 Q1	$2.44M	Sell	74,023 -242	-0.3%	-$7.69K	0.59%	67
2014 Q4	$2.19M	Hold	74,265	–	–	0.55%	70
2014 Q3	$2.08M	Sell	74,265 -3,490	-4%	-$98K	0.53%	75
2014 Q2	$2.19M	Buy	77,755 +5,315	+7%	+$152K	0.53%	73
2014 Q1	$2.21M	Buy	72,440 +13,658	+23%	+$407K	0.53%	69
2013 Q4	$1.71M	Hold	58,782	–	–	0.46%	81
2013 Q3	$1.6M	Sell	58,782 -2,616	-4%	-$71.2K	0.46%	79
2013 Q2	$1.63M	Buy	+61,398	New	+$1.7M	0.49%	76

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Mesirow Financial Investment Management - Fixed Income's PFE Position: Q1 2017 in Review

Mesirow Financial Investment Management - Fixed Income sold out of Pfizer (PFE) in Q1 2017, closing a stake of 19,101 shares — an estimated $588K sold.

Mesirow Financial Investment Management - Fixed Income first reported a position in PFE in Q2 2013 and held it in 15 quarters. The position peaked at $2.44M in Q1 2015. 2,075 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

Mesirow Financial Investment Management - Fixed Income reported no remaining Pfizer position as of Q1 2017 after selling out during the quarter.
Mesirow Financial Investment Management - Fixed Income sold 19,101 Pfizer shares in Q1 2017, an estimated $588K.
Mesirow Financial Investment Management - Fixed Income first reported a position in Pfizer in Q2 2013 and held it in 15 quarters.
Mesirow Financial Investment Management - Fixed Income's Pfizer position peaked at $2.44M in Q1 2015.
2,075 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on Mesirow Financial Investment Management - Fixed Income's 13F filing for Q1 2017, filed 25 Apr 2017.